CE Marked lipolytic/mesotherapy product in many EU markets (classification may vary by country and local regulatory framework).
Manufactured by Caregen Co., Ltd., a biotechnology company specialising in peptide Based cosmeceuticals and aesthetic products, under applicable cosmetic/medical device quality standards.
Intended for professional use only, in accordance with local regulations governing injection lipolysis and mesotherapy treatments.
CE Marked lipolytic/mesotherapy product in many EU markets (classification may vary by country and local regulatory framework).
Manufactured by Caregen Co., Ltd., a biotechnology company specialising in peptide Based cosmeceuticals and aesthetic products, under applicable cosmetic/medical device quality standards.
Intended for professional use only, in accordance with local regulations governing injection lipolysis and mesotherapy treatments.
Dermaheal LL is a professional lipolytic mesotherapy solution designed to reduce localized fat deposits and cellulite and improve skin elasticity and contour. Formulated with a biomimetic peptide complex, phosphatidylcholine (soy lecithin) and L-carnitine, along with growth factors and nutrient co-factors, it helps break down stored fat, enhance lipid metabolism and support natural elimination via the body’s metabolic and lymphatic systems. It is used in non-surgical body contouring for areas such as double chin, cheeks, neck, abdomen, hips, thighs, buttocks, knees, arms and back, offering a minimally invasive alternative or complement to more invasive fat reduction procedures.
Bnefits
Dissolves and reduces localized fat deposits in problem areas (e.g. double chin, abdomen, hips, thighs, buttocks, knees, arms, back).
Helps visibly reduce the appearance of cellulite and improve skin texture.
Contours and slims treated areas, enhancing body shape without surgery.
Improves skin elasticity and firmness by supporting collagen and elastin fibres.
Stimulates lipid metabolism and promotes gradual, natural elimination of broken-down fat via metabolic and lymphatic pathways.
Can provide long-lasting results when combined with stable body weight and healthy lifestyle habits.
Minimally invasive outpatient procedure, typically without need for anaesthesia and minimal downtime.
Indications
Localized subcutaneous fat deposits resistant to diet and exercise (e.g. abdomen, flanks, hips, thighs, buttocks, knees, upper arms, back).
Double chin, lower facial fullness and fat under the jawline in suitable candidates.
Cellulite and uneven skin surface in body areas such as thighs and buttocks.
Mild to moderate loss of skin firmness in areas with localized adiposity.
Patients seeking non-surgical body contouring / injection lipolysis options.
• Decapeptide-4 (CG-IDP2): biomimetic peptide that promotes lipolysis and optimises local metabolism, supporting fat breakdown and improving tissue firmness.
Lipolytic and metabolic actives:
• Hydrogenated Lecithin (Phosphatidylcholine, often from soy lecithin): phospholipid that emulsifies and destabilises adipocyte membranes, aiding breakdown of stored fat and facilitating its removal.
• L-Carnitine: physiological carrier molecule that transports free fatty acids into mitochondria where they are oxidised for energy, supporting utilisation of released fats.
Additional active complex (as described by several distributors):
• sh-Oligopeptide-2 (IGF-1 analogue) and Copper Tripeptide-1: may be present as part of the broader Dermaheal line’s peptide/growth factor platform to support microcirculation, tissue repair and elasticity.
Supportive components:
• Multi-vitamin, amino acid, mineral, coenzyme and nucleic acid complexes (numbers vary by source; often described as similar platform to other Dermaheal mesotherapy products) to provide antioxidant support, improve microcirculation, and enhance tissue regeneration.
Vehicle and excipients:
• Water (Aqua) and buffering/stabilising excipients suitable for sterile mesotherapy use; exact INCI list can vary by market and regulatory classification.
Formulation
Sterile lipolytic mesotherapy solution intended for injection into subcutaneous fat compartments and/or for microneedling/mesoroller application in some protocols.
Key active triad: biomimetic peptide complex, phosphatidylcholine (soy lecithin) and L-carnitine.
Non-surgical injection lipolysis product to help the body gradually dissolve and remove excess fat and cellulitis.
Clear solution supplied in multi-use treatment pack (10 vials x 5ml each).
Packaging
Box containing 10 sterile glass vials x 5 ml (total 50 ml).
Each vial is intended for use on a single patient per session (1 vial per treatment area/session, according to protocol).
Outer carton labelled with product name, indication (lipolytic / anti-cellulite), batch number, expiry date (shelf life typically 2 years from production), storage instructions and manufacturer details.
Usage
For professional use only by trained and appropriately licensed medical / aesthetic practitioners.
Dermaheal LL is injected with a thin needle directly into the subcutaneous fatty tissue of the treatment area, using appropriate mesotherapy / lipolysis techniques and observing strict aseptic procedures.
The procedure is usually performed on an outpatient basis, typically without anaesthesia or with topical/local anaesthetic as per practitioner preference and patient comfort.
Recommended treatment course (typical): 2–4 sessions at intervals of approximately 6–8 weeks between sessions.
Some distributors suggest 1 session per week for a limited course in certain protocols; always follow manufacturer and local clinical guidelines.
No bandages or compression garments are usually required after treatment, unless the practitioner advises otherwise.
After treatment, patients are generally able to return to normal daily activities; mild transient swelling or tenderness in treated areas is common.
Patients should be advised to maintain a stable weight, healthy diet and physical activity to support and sustain clinical results.
Avoid aggressive massage, heat exposure (sauna, hot tubs), vigorous exercise or other procedures in treated areas for a short period post-treatment as directed by practitioner.
Contraindications
Known persistent hypersensitivity or allergy to any active ingredient (e.g. phosphatidylcholine/soy lecithin, L-carnitine, biomimetic peptides) or excipients.
Pregnancy or breastfeeding.
Autoimmune disorders or uncontrolled systemic illnesses (e.g. uncontrolled diabetes, active cancer) unless specifically assessed and cleared by a physician.
Coagulation/blood clotting disorders or current anticoagulant therapy when injection is planned (relative contraindication).
Active skin infections, inflammation, dermatitis or other acute skin diseases at or near the proposed injection sites.
Simultaneous or very recent deep chemical peels, laser resurfacing or other aggressive procedures in the same area.
History of severe allergies, anaphylaxis or keloid formation, depending on practitioner risk assessment.
Not suitable for patients with major obesity as a weight-loss treatment; it is intended for localised fat deposits only.
Adverse Effects
Transient redness, swelling, tenderness, warmth or mild bruising at injection sites.
Possible temporary nodules or induration in treated areas as fat breakdown occurs, usually resolving over time.
Occasional mild pain or discomfort during or shortly after injection.
Rare allergic or hypersensitivity reactions, including itching, rash or more severe responses; medical evaluation is required if significant reaction occurs.
Very rare risk of infection, uneven fat dissolution, contour irregularity, necrosis or other serious complications if technique is improper or aseptic protocol is not followed.
Short-term limitations in comfort with pressure on treated areas (e.g. when sitting) due to local tenderness.
Storage Conditions
Store unopened vials at controlled room temperature, typically between 2°C and 25°C (some distributors recommend 2–25°C).
Protect from direct sunlight and overheating; do not freeze.
Keep vials in original outer carton until use to protect from light.
Shelf life is generally 2 years from date of production when stored correctly.
Once opened, any remaining product should be stored in a refrigerator (2–8°C) and used within a short period (e.g. up to 5 days) or discarded, following local regulations and infection-control best practice.
Keep out of reach of children and unauthorised individuals.
Duration
Commonly recommended course comprises 2\u20134 treatment sessions spaced 6\u20138 weeks apart. Full results are progressively visible over several weeks to months following each session as fat is gradually broken down and eliminated. Maintenance treatments may be considered if clinically indicated and according to practitioner assessment.
Onset
Initial effects generally become apparent after around 4 weeks, as the treated fat tissue gradually dissolves and the body metabolises and eliminates the breakdown products. Further improvement in contour, cellulite and skin smoothness continues over subsequent weeks and after completion of the full treatment course. Results are considered long-lasting if body weight remains stable and lifestyle factors do not promote new fat accumulation.
